They suppressed the growth of lymphoma and myeloma cell lines via disturbing normal expression level of Bcl and c-myc genes, while increased the expression level of cyclin-dependent kinase inhibitor p27 (KIP1) [121]. This evidence concerns the gene CDKN1B and lymphoma.